Pediatric growth percentiles, drug dosing, neonatal risk calculators, and vital signs.
Diagnoses hypertension in pediatric patients based on the 2017 guidelines from the American Academy of Pediatrics
Weight-based adrenaline dosing for children (arrest / anaphylaxis).
Weight-based amoxicillin dosing for children by indication.
Assesses neonatal vitality at 1 and 5 minutes after birth using 5 clinical criteria
Determines likelihood of pediatric patients developing childhood asthma in children ≤3 years old with recurrent wheezing episodes.
Weight-based amoxicillin-clavulanate dosing (amoxicillin component).
Weight-based azithromycin: day-1 dose (5-day course).
Predicts likelihood of bacterial (versus aseptic) meningitis in children with CSF pleocytosis. The score helps clinicians distinguish between bacterial and aseptic meningitis to support safe discharge decisions while maintaining appropriate caution for this serious condition.
Weight-based TMP-SMX dosing (TMP component).
New Ballard Score: estimate gestational age from neuromuscular and physical maturity.
Bedside PEWS: 7-item early warning score for hospitalized children (Parshuram).
Quantifies post-operative pain for children aged 1-7 years using observational behavioral indicators
Modified Bell staging for necrotizing enterocolitis (Walsh & Kliegman 1986): stages IA/IB (suspected), IIA/IIB (definite), IIIA/IIIB (advanced/perforated) from systemic, intestinal, and radiographic findings. Merges the duplicate 'Modified Bell NEC staging' entry.
Brighton PEWS: behaviour, cardiovascular, respiratory domains.
Classifies unexplained events in infants <1 year old and replaces the Apparent Life-Threatening Events (ALTE) classification. Determines risk stratification and management recommendations for infants who have experienced brief, resolved episodes of concerning symptoms.
Classifies unexplained events and improves on the original BRUE criteria by providing sophisticated risk prediction models for serious underlying conditions and event recurrence in infants <1 year old. Uses derived models to predict risk of serious diagnosis and recurrent events.
Pediatric burn size by the Lund-Browder chart.
Screens for delirium in pediatric patients through behavioral assessment of awareness, cognition, and psychomotor symptoms.
Predicts clinically significant head injuries in children aged 0-16 years to guide CT imaging decisions. Identifies high-risk factors for neurologic intervention and medium-risk factors for brain injury on CT.
CDC Boys BMI-for-age: LMS z-score and percentile for age 24-240 months.
CDC Boys weight-for-age: LMS z-score and percentile for age 24-240 months.
CDC Girls BMI-for-age: LMS z-score and percentile for age 24-240 months.
CDC Girls weight-for-age: LMS z-score and percentile for age 24-240 months.
Weight-based cefaclor dosing for children.
Weight-based cefadroxil dosing for children.
Weight-based cefdinir dosing for children.
Weight-based cefepime dosing for children (IV).
Weight-based cefixime dosing for children (oral).
Weight-based cefotaxime dosing for children (IV/IM), indication-adjusted.
Weight-based ceftazidime dosing for children (IV).
Weight-based ceftibuten dosing for children (oral).
Weight-based ceftriaxone dosing for children (IV/IM), indication-adjusted.
Weight-band celecoxib dosing for juvenile rheumatoid arthritis (oral).
CHALICE rule: which children with head injury need CT.
Decision rule for CT head in children after head injury.
Quantifies post-operative pain in pediatric patients aged 1-5 years using behavioral observations
Weight-based ciprofloxacin dosing for children (oral).
Weight-based clarithromycin dosing for children (oral).
Weight-based clindamycin dosing for children (oral), indication-adjusted.
Assess degree of dehydration in children with gastroenteritis.
Assess postoperative pain in neonates (0-6 months).
Weight-based dexamethasone dosing for children, indication-adjusted.
Classifies dehydration severity in children under 5 years old with acute diarrhea using four clinical assessment parameters.
Weight-based diazepam dosing for children, indication-adjusted.
Weight-based diclofenac dosing for children (oral).
Neonatal respiratory distress severity (5 signs, 0-10).
Weight-based doxycycline dosing for children (oral/IV).
Neurological criteria for newborn gestational age assessment.
Duloxetine dosing for pediatric generalized anxiety disorder.
Aids in management of infants with neonatal abstinence syndrome (NAS) by focusing on functional assessment rather than symptom scoring. Emphasizes nonpharmacologic interventions and family-centered care to optimize infant functioning.
21-item scoring system for neonatal abstinence syndrome.
Behavioral pain assessment for children 2 months-7 years (Face, Legs, Activity, Cry, Consolability).
10-sign clinical scale estimating percent dehydration in children 1-60 months with acute gastroenteritis.
Predicts coronary artery aneurysm risk in Kawasaki disease to select patients for IVIG therapy.
Predicts risk of hyperbilirubinemia in neonates based on total serum bilirubin measurement using the Bhutani nomogram. Identifies infants at risk for subsequent significant hyperbilirubinemia.
Weight-based pediatric imipenem dosing (15-25 mg/kg q6h) with absolute maximum caps.
Determines what immunizations/vaccinations are due based on patient's age according to CDC vaccination guidelines. This clinical decision support tool helps healthcare providers identify appropriate vaccinations for pediatric and adult patients based on standardized immunization schedules. The calculator provides general vaccination recommendations but requires clinical judgment and knowledge of patient's vaccination history for optimal use.
Weight-based infant acetaminophen dosing 10-15 mg/kg q4-6h with daily maximum.
Assesses risk of traumatic brain injury in infants with asymptomatic head injury and isolated scalp hematoma. The Infant Scalp Score (ISS) is a validated clinical tool specifically designed for infants ≤12 months old who present with isolated scalp hematoma after head trauma but are otherwise asymptomatic. The score stratifies risk for clinically important traumatic brain injury (ciTBI) or TBI on computed tomography (CT) to help guide clinical decision-making. This tool is particularly valuable in the pediatric emergency setting where infants are difficult to assess clinically and are most sensitive to ionizing radiation effects. The score considers patient age, hematoma size, and location to calculate risk, helping clinicians determine which infants require neuroimaging versus those who can be safely observed.
Estimates volume of donor RBCs needed for intrauterine transfusion (IUT) in fetal anemia cases. Used primarily for severe fetal anemia in hemolytic disease of the fetus and newborn (HDFN) when maternal RBC alloantibodies threaten fetal health. Calculates precise transfusion volume to achieve target hematocrit while minimizing risks of over- or under-transfusion.
Diagnoses Kawasaki Disease using fever duration and principal clinical features. Kawasaki disease is a systemic vasculitis of childhood that can cause coronary artery aneurysms if untreated. Diagnosis requires fever ≥4 days plus ≥4 of 5 principal clinical features, or fever ≥5 days plus 2-3 features (incomplete Kawasaki).
Stages acute kidney injury in children by creatinine rise and urine output (KDIGO 2012).
Predicts IVIG resistance in Kawasaki disease from pre-treatment labs and demographics.
Assesses functional status in pediatric patients (under 16 years) using parent description of child's play activity and daily function, primarily used in pediatric oncology to evaluate treatment response and disease progression
Hourly maintenance fluid rate for children by the Holliday-Segar 4-2-1 rule.
Calculates maintenance fluid requirements by weight using the Holliday-Segar method
Pediatric metoclopramide dosing: 0.1 mg/kg/dose IV/IM/PO every 6-8 hours, maximum 10 mg per single dose. Computes the per-dose range and enforces the absolute cap.
Predicts future asthma onset probability in pediatric patients ≤3 years old with recurrent wheezing episodes
Stratifies severity of opioid withdrawal in neonates and guides pharmacologic treatment decisions
Modified Sarnat staging for hypoxic-ischemic encephalopathy (NICHD/Shankaran): 6 neurologic categories each scored normal(0)/mild(1)/moderate(2)/severe(3); overall stage = worst category. NICHD trial rule: moderate/severe HIE if ≥3 categories are moderate or severe.
Calculates risk of early-onset neonatal sepsis based on maternal intrapartum risk factors for newborns ≥34 weeks gestation. Uses multivariate predictive model to estimate probability of culture-positive sepsis within 72 hours of birth.
Neonatal hypoglycemia evaluation thresholds (AAP Committee on Fetus and Newborn 2011): symptomatic infants treat at <40 mg/dL; asymptomatic at-risk infants use age-dependent thresholds (<25 mg/dL at 0-4h, <35 mg/dL at 4-24h trigger feed-and-recheck).
Neonatal Infant Pain Scale (NIPS, Lawrence 1993): facial expression, cry, breathing pattern, arms, legs, and state of arousal; total 0-7. Score >3 indicates pain.
Estimates total blood volume to remove and crystalloid volume to infuse in neonatal polycythemia
Neonatal/infant eGFR by the bedside Schwartz equation with age-appropriate k constant: eGFR = k × height / SCr, with k = 0.33 for preterm infants and k = 0.45 for term infants under 1 year. SCr in mg/dL, height in cm; result in mL/min/1.73m².
New Ballard Score for gestational age assessment (Ballard 1991): 6 neuromuscular + 6 physical maturity items, each scored per the Ballard chart; total −10 to 50 maps to gestational age: GA (weeks) = 24 + 0.4 × total.
Predicts outcomes and assists in treatment decisions for pediatric patients with acute respiratory failure. This validated tool helps determine the need for extracorporeal membrane oxygenation (ECMO) and assesses the severity of acute lung injury and acute respiratory distress syndrome (ARDS). The index quantifies the intensity of ventilatory support required to maintain adequate oxygenation.
The PASS is a 3-item ED asthma severity score (wheezing, work of breathing, prolonged expiration), each 0-2. Total 0-6.
The PCDAI measures Crohn's disease activity in children from history, exam and labs. Total 0-100: <10 inactive, 10-30 mild, >30 moderate-severe.
Samuel score: risk stratify suspected appendicitis in children.
Pediatric Glasgow Coma Scale: Eye 1-4 (as adult), Verbal 1-5 modified (5 appropriate words/smiling/cooing, 4 consolable crying, 3 persistently irritable, 2 restless/agitated, 1 none), Motor 1-6 (as adult). Total 3-15.
Holliday-Segar 4-2-1 rule for hourly pediatric maintenance fluids: 4 mL/kg/h for the first 10 kg, 2 for the next 10 kg, 1 for each kg above 20.
Age-adjusted SIRS criteria from the 2005 International Pediatric Sepsis Consensus Conference: >=2 of 4 (temperature, heart rate, respiratory rate, leukocytes), one of which must be abnormal temperature or leukocyte count.
General pediatric weight-based dose calculation: dose (mg) = weight (kg) × prescribed mg/kg, capped at an optional maximum single dose. A generic arithmetic aid — the prescriber must confirm the mg/kg value and maximum against a drug-specific reference.
Pediatric End-Stage Liver Disease (PELD) score for children <12 years: 4.80×ln(bilirubin) + 18.57×ln(INR) − 6.87×ln(albumin) + 4.36×(age <1 yr) + 6.67×(growth failure). Values <1 set to 1 before ln. Higher = higher waitlist mortality.
Identifies febrile infants 29-56 days at low risk of serious bacterial infection. All criteria must be met.
International consensus criteria for pediatric sepsis and septic shock diagnosis based on organ dysfunction assessment. Developed by the SCCM Pediatric Sepsis Definition Task Force and published in JAMA 2024. Identifies potentially life-threatening organ dysfunction in children with suspected infection.
PIM3 predicts PICU mortality from admission variables via logistic regression. Inputs are the first values at/after first ICU contact (within 1h of arrival).
The PRAM is a 12-point ED asthma severity score: O2 saturation, suprasternal retractions, scalene muscle use, air entry, wheezing. Covers curated 'Pediatric Respiratory Assessment Measure' and 'PRAM'.
pRIFLE pediatric acute kidney injury classification (Akcan-Arikan 2007): Risk (eGFR ↓≥25% or UO <0.5 mL/kg/h × 8 h), Injury (eGFR ↓≥50% or UO <0.5 × 16 h), Failure (eGFR ↓≥75% or eGFR <35 or UO <0.3 × 24 h or anuria × 12 h), Loss (persistent failure >4 weeks), End-stage (>3 months). Class = worst of eGFR and urine-output criteria.
The PUCAI is a 6-item noninvasive index for ulcerative colitis activity in children (no labs/endoscopy). Total 0-85.
Low-risk criteria for serious bacterial infection in febrile infants <= 60 days; all must be met.
Assess severity of respiratory distress in neonates.
Pediatric shock index with age-specific cutoffs: 4-6y >1.22, 7-12y >1.00, 13-16y >0.90.
SNAPPE-II: neonatal illness severity (9 items, first 12h).
Step-by-Step approach (Gomez 2016) to identify febrile infants ≤90 days at low risk of invasive bacterial infection (bacteremia/meningitis). Sequential rule: ill appearance, age ≤21 days, leukocyturia, procalcitonin ≥0.5 ng/mL, or CRP >20 mg/L / ANC >10,000 per mm³ each classify the infant as NOT low risk; otherwise low risk.
4-item pediatric malnutrition screening: 0 low, 1-3 medium, 4-5 high risk.
Tal score for bronchiolitis severity (Tal 1983): respiratory rate, wheezing, cyanosis, and retractions each scored 0-3; total 0-12. ≤4 mild, 5-8 moderate, ≥9 severe.
Modified Taussig croup score: two-item severity scale for viral croup in children. Stridor and retractions are each graded 0-3 (none; only on crying/exertion; at rest; severe/biphasic). Total 0-6: 1-2 mild, 3-4 moderate, 5-6 severe.
Validated assessment tool for evaluating opioid and benzodiazepine withdrawal severity in pediatric patients. The WAT-1 systematically assesses 12 clinical parameters across multiple domains including neurologic irritability, motor symptoms, respiratory distress, and gastrointestinal symptoms to guide withdrawal management in children.
Assess severity of croup (laryngotracheobronchitis) in children.
Wood-Downes score modified by Ferres for pediatric asthma/bronchiolitis severity: wheezing (0-3), retractions (0-3), air entry (0-3), respiratory rate (0-3), heart rate (0-1), cyanosis (0-1). Total 0-14: 0-3 mild, 4-7 moderate, 8-14 severe.
Yale Observation Scale (McCarthy 1982): 6 observational items (cry quality, reaction to parents, state variation, color, hydration, response to social overtures), each scored 1 (normal), 3 (moderate impairment), or 5 (severe impairment). Total 6-30; higher scores indicate greater risk of serious illness in the febrile young child.
Clinical Decision Support (CDS) Notice & Legal Disclaimer
All calculations and clinical scoring tools in this directory are intended strictly for educational and decision-support use by licensed medical practitioners. They do not constitute autonomous medical advice or direct treatment orders. See the full DexaMed Medical Disclaimer.